2 AUSTRALASIAN DENTIST PEOPLE Tara Cullen has been appointed Chief Executive Officer of the Modern Dental Pacific Group. Tara has been part of the Group since 2013 and has worked closely with customers, clinicians, and teams across Australia and New Zealand. Tara brings extensive senior leadership experience across healthcare, dental and medical devices. Since joining Modern Dental Pacific, she has held several senior roles, including Chief Operating Officer and Group Director of Sales and Marketing, where she led operations, commercial performance, brand building, and customer experience across the region. At the heart of Tara’s leadership approach is a strong commitment to supporting clinicians and improving patient health outcomes. She believes that trusted customer partnerships and Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, the world’s largest provider of healthcare solutions to officebased dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. Mr Lowery brings more than two decades of healthcare expertise to Henry Schein, with a strong track record of scaling complex businesses to drive significant growth and sustained value creation. Most recently, he served as Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific (NYSE: TMO), leading the Fisher Scientific distribution channel’s above-market performance. His experience growing distribution and owned product businesses – including manufacturing, R&D, marketing, and sales functions – closely aligns with Henry Schein’s business model, positioning him well to guide the Company’s next phase of growth and continued execution of its BOLD+1 strategic plan. “I am honored to join Henry Schein well-supported employees are essential to delivering consistent quality, dependable service, and high clinical standards, enabling better outcomes for patients today and into the future. Importantly, there is no change to how we work with you. The teams you know remain in place, and our commitment to quality, consistency, and partnership continues. “Everything we do starts with our customers and the patients they care for. I’m proud of the partnerships we’ve built and look forward to continuing to support you with the quality, service, and care you expect from us.” – Tara Cullen We thank James Squirrell for his leadership and contribution to the business and look forward to continuing our partnership with you under Tara’s leadership. u at such a pivotal moment. This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership,” said Mr Lowery. “I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation.” Prior to joining Thermo Fisher, Mr Lowery worked in leadership roles for Maytag Corporation and General Motors. He holds a master’s degree in manufacturing management from Kettering University (formerly General Motors Institute of Engineering and Management) and a bachelor’s degree in mechanical engineering from Tennessee Technological University. “I am very pleased to welcome Fred to Henry Schein. Beyond his extensive operational experience, he brings a leadership philosophy that reflects the New CEO of Modern Dental Pacific Group Henry Schein names Frederick M. Lowery as Chief Executive Officer values that have long defined our company,” said Mr Bergman. “Fred understands the critical role we play in supporting dental and medical practitioners, and he is exceptionally well equipped to lead Henry Schein into its next phase of growth.” “On behalf of the Board, I would like to thank Stan for his exceptional leadership and invaluable contributions over more than three decades,” said Phil Laskawy, Lead Director and Chair of the Nominating and Governance Committee at Henry Schein. “After a comprehensive search process, we are confident that Fred is the right successor to honor Henry Schein’s proud heritage. With extensive commercial, logistics, and manufacturing expertise, and a focus on customer satisfaction, he has the combination of experience and capabilities necessary to accelerate growth and value creation.” “We are excited about our strategic partnership with Henry Schein and look forward to supporting the next chapter of the Company’s journey under Fred’s leadership,” said Max Lin, Board Member and Vice Chair of the Nominating and Governance Committee at Henry Schein and Partner at KKR. “We believe Fred brings a unique combination of healthcare distribution experience, operational best practices, and accountable leadership that will accelerate our strategic initiatives and further differentiate Henry Schein as a world-class business.” u
RkJQdWJsaXNoZXIy MTc3NDk3Mw==